of repeated doses of tiopronin [N-(2-mercaptopropionyl)glycine] on elimination of 203Hg were determined by means of whole body counting after intra v enous injection of 203Hg-methylmercuric chloride (Me 203HgCl), phenylmercuric acetate (Ph 203HgAc) or mercuric chloride (203HgCl2) into mice. The tissue distribution of 203Hg-mercury compounds was also observed, using a autoradiographic technique, and the effects of tiopronin were compared with those of 2,3-dimercaptopropanol (BAL). Subcutaneous administrations of tiopronin stimulated excretion of radioele ments from the whole body of mice given Me 203HgCl, the biological half-life of Me 20 3HgCl being shortened from 6 .5 to 2.9 days. Autoradiographic studies showed that the radioactivities after Me 203HgCl injection were less in all organs in the tiopronin treated mice than in the controls after a temporary rise of radioactivities in the blood and secretory glands. The excretion of 203Hg from the mice given Ph 203HgAc or 20 3HgCl2 was also stimulated by tiopronin treatment , but the stimulation was much less than when the mice had been given Me 203HgCl. Repeated administrations of BAL remarkably increased the excretion of radioelement in the mice given Ph 203HgAc or 203HgCl2 but not Me 203HgCl. However, autoradiograms demonstrated that BAL enhanced accumulation of these compounds in the nervous system and muscle compared tic ith the control after injection of three different types of mercury compounds .
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A number of reports have been published on Minamata Disease, a chronic methylmercury poisoning resulting from the ingestion of fish contaminated with mercurial wastes (1-3). Chelating agents, 2,3-dimercaptopropanol (BAL) and calcium disodium edetate, were clinically prescribed for treatment of these patients. However , the results obtained were not always satisfactory (4).
Certain chelating agents such as BAL and cysteine enhance the accumulation of mercury compounds in different tissues, especially in the brain of experimental animals (5-8) . Tio pronin has been recently reported to promote excretion of mercury compounds in man (9) and animals (10-11). There is, however, no actual proof that tiopronin is clinically effective for Minamata Disease.
In the present investigation, the effects of tiopronin on the elimination and distribution of 203Hg-mercury compounds were compared with those of BAL by means of whole body counting and whole body autoradiography, respectively .
MATERIALS AND METHODS

Animals and Compounds
Animals used (ddY-SLC strain) were adult male mice , weighing from 20 to 24 g, fed ad libituin a normal animal diet (Oriental Yeast Co., Ltd.). 203Hg-labeled methylmercuric chloride (Me 203HgC1) and phenylmercuric acetate (Ph 203HgAc) were purchased from the New England Nuclear Corp. (U.S.A.). 203Hg-labeled mercuric chloride (203HgC12) was obtained from Daiichi Pure Chemicals Co., Ltd. Tiopronin was a product of Santen Pharmaceutical Co., Ltd., and the BAL used was a reagent grade of Wako Pure Chemical Industry, Ltd.
Testing the effect of drugs on excretion of 203Hg-mercury compounds Me 203HgCl, Ph 203HgAc and 203HgC12 having specific activities of 36, 56 and 65 >>Ci;` mgHg, respectively, were used. In each experiment, 25 mice were separated into 5 groups and treated as follows: (1) Control group; No drug treatment after V03Hg-mercury compound injection, (2) Tiopronin-treated group (A); Tiopronin was given daily for 6 days. com mencing with the day of injection of 203Hg-mercury compound, (3) Tiopronin-treated group (B); Tiopronin was given daily for 6 days from day 7 after injection of 203Hg-mercury com pound, (4) Pre-mixed group; No drug treatment after injection of 203Hg-mercury compound. The mercury compound was mixed in a test tube with twice the equimolar amount of tio pronin, and this mixture was injected, (5) BAL-treated group; BAL was given daily for 6 days, commencing with the day of injection of 203Hg-mercury compound.
2031g-mercury compounds and their mixtures with tiopronin were given into the tail vein at a dose of 0.5 mgHg/kg. Tiopronin (dissolved in saline, adjusted to pH 7.0 with NaOH) and BAL (dissolved in olive oil) were given s.c. at a dose of 5.0 mg/kg. The volume ,of the infusate was 0.1 ml/20 g of body weight.
During the experiment period (14 days), animals were placed individually in metabolism cages in order to prevent contamination with their excrement.
Whole body radioactivity of animals was counted daily for 13 days between 9:00 a.m.
and 10:00 a.m. and BAL or tiopronin was administered immediately after the counting. given to the animals on the day of sacrifice. Mice were also given drugs immediately after injection of 203Hg-mercury compounds and sacrificed 1 hr later. According to the methods of Ullberg modified by Matsuoka (12), the mice were immersed in the mixture of dry-ice and acetone, and whole body autoradiography was performed. Sagittal sections of 40,E thickness were exposed to industrial X-ray film (Sakura type N) for 7 to 30 days.
RESULTS
,ct of drugs on elimination of 2D3Hg-mercury compounds E -f Figure 1 shows the time-course of the effect of drugs on whole body retention of '-"Hg mercury compounds expressed as mean percentage of injection dose in the semilogarithmic graph. Me 203HgC1: Whole body retention of 203Hg of the control group decreased linearly, and the biological half-life was 6.5 days. In the tiopronin-treated groups (A) and (B), the elimination rates were remarkably enhanced by tiopronin administration, and biological half-life of both groups was about 2.9 days during the treatment period. On the other hand, a significant increase in the elimination rates was not observed in the pre-mixed and BAL-treated groups.
P/i 211H,-Ac: Whole body retention of 203Hg of the control group decreased in a curve for a few days after injection, and thereafter, decreased in a straight line. In the tiopronin-treated groups (A), (B) and pre-mixed group, the elimination rates increased slightly. In the BAL-treated group, the increase in the elimination rate was comparable to that of the tiopronin-treated group (A) in a few days, and thereafter was enhanced to a considerable extent. This may be due to the potent activity of BAL in initiating excretion of inorganic mercury to which Ph 111H-Ac was converted in the animal tissues (13-14). On the contrary, the elimination rate remarkably increased in the BAL-treated group. The biological half-life of the control group was 4.1 days, while that of the BAL-treated group v,-«s 0.8 days.
Effect of tiopronin on 203Hg content in organs on day 14 after injection of 203Hg-mercury compounds: Table 1 shows Sulfhydryl compounds are well known to make stable complexes with mercury com pounds in vitro. Therefore, it seems that the complex formation of tiopronin with mercury compounds plays an important role in enhancement of the excretion of mercury compounds after tiopronin administration. However, it was also demonstrated that when the mixture of tiopronin and mercury compounds (mole ratio, 2:1) was injected into mice, the stimulatory effect on the excretion of mercury compounds was much less than when a large excess amount of tiopronin was given repeatedly after 203Hg-mercury compound injection. These results indicate that the complex of tiopronin and mercury compounds formed by mixing may be easily decomposed in the animal body, and that the separated mercury compounds may be taken up by endogenous cysteine, glutathione, or protein sulfhydryl groups when tiopronin is not present in excess of the mercury compounds. This consideration is supported by the data of Funae et al. (15) who showed that the stability constant of the mercury complex with tiopronin was less than that with glutathione or cysteine.
In mice treated with Me 203HgC1, the tiopronin-induced temporary rise in the concen tration of 203Hg in the blood and secretory glands may be associated with acceleration of 208Hg elimination from the whole body . In mice given Ph 203HgAc or 203HgC12, the ac celerated reduction of tiopronin was due to the removal of "13Hg from the kidney.
The mechanism of accelerated excretion by tiopronin after Ph 203HgAc or =oiHgCF_ seems to be considerably different from that after Me °13HgCl .
Among various drugs (9-11, 16-21) used experimentally for the release of mercury compounds from the organism, tiopronin appears to be one of the most effective . Moreover, this compound has the distinct advantage of being much less toxic (22) than the compounds mentioned above.
From the above considerations, tiopronin is considered to have a therapeutic value in cases of mercury poisoning, particularly methylmercury poisoning .
